» Articles » PMID: 18512079

Genetic Studies of African Populations: an Overview on Disease Susceptibility and Response to Vaccines and Therapeutics

Abstract

Africa is the ultimate source of modern humans and as such harbors more genetic variation than any other continent. For this reason, studies of the patterns of genetic variation in African populations are crucial to understanding how genes affect phenotypic variation, including disease predisposition. In addition, the patterns of extant genetic variation in Africa are important for understanding how genetic variation affects infectious diseases that are a major problem in Africa, such as malaria, tuberculosis, schistosomiasis, and HIV/AIDS. Therefore, elucidating the role that genetic susceptibility to infectious diseases plays is critical to improving the health of people in Africa. It is also of note that recent and ongoing social and cultural changes in sub-Saharan Africa have increased the prevalence of non-communicable diseases that will also require genetic analyses to improve disease prevention and treatment. In this review we give special attention to many of the past and ongoing studies, emphasizing those in Sub-Saharan Africans that address the role of genetic variation in human disease.

Citing Articles

Multi-omics approaches for understanding gene-environment interactions in noncommunicable diseases: techniques, translation, and equity issues.

Alemu R, Sharew N, Arsano Y, Ahmed M, Tekola-Ayele F, Mersha T Hum Genomics. 2025; 19(1):8.

PMID: 39891174 PMC: 11786457. DOI: 10.1186/s40246-025-00718-9.


No Association Between Gene Polymorphisms with Hypertension in a South African Population.

Sharma J, Fokkens H, Laubscher R, Apalata T, Nomatshila S, Alomatu S Diabetes Metab Syndr Obes. 2024; 17:1853-1865.

PMID: 38706806 PMC: 11069114. DOI: 10.2147/DMSO.S452272.


Population-enriched innate immune variants may identify candidate gene targets at the intersection of cancer and cardio-metabolic disease.

Yeyeodu S, Hanafi D, Webb K, Laurie N, Kimbro K Front Endocrinol (Lausanne). 2024; 14:1286979.

PMID: 38577257 PMC: 10991756. DOI: 10.3389/fendo.2023.1286979.


The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies.

Ankunda V, Katende J, Oluka G, Sembera J, Baine C, Odoch G Front Immunol. 2024; 15:1325387.

PMID: 38469296 PMC: 10926532. DOI: 10.3389/fimmu.2024.1325387.


HLA haplotype frequencies and diversity in patients with hemoglobinopathies.

Scigliuolo G, Boukouaci W, Cappelli B, Volt F, Rivera Franco M, Dhedin N EJHaem. 2023; 4(4):963-969.

PMID: 38024588 PMC: 10660433. DOI: 10.1002/jha2.763.


References
1.
Tang J, Tang S, Lobashevsky E, Zulu I, Aldrovandi G, Allen S . HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners. AIDS Res Hum Retroviruses. 2004; 20(1):19-25. DOI: 10.1089/088922204322749468. View

2.
Adebamowo C, Famooto A, Ogundiran T, Aniagwu T, Nkwodimmah C, Akang E . Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat. 2007; 110(1):183-8. DOI: 10.1007/s10549-007-9694-5. View

3.
Marchant A, Pihlgren M, Goetghebuer T, Weiss H, Ota M, Schlegel-Hauter S . Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infants. J Infect Dis. 2006; 193(11):1598-605. DOI: 10.1086/503775. View

4.
Alm J, Sanjeevi C, Miller E, Dabadghao P, Lilja G, Pershagen G . Atopy in children in relation to BCG vaccination and genetic polymorphisms at SLC11A1 (formerly NRAMP1) and D2S1471. Genes Immun. 2002; 3(2):71-7. DOI: 10.1038/sj.gene.6363834. View

5.
Wiertsema S, Baynam G, Khoo S, Veenhoven R, van Heerbeek N, Zhang G . Impact of genetic variants in IL-4, IL-4 RA and IL-13 on the anti-pneumococcal antibody response. Vaccine. 2006; 25(2):306-13. DOI: 10.1016/j.vaccine.2006.07.024. View